METHOD FOR RELIEVING PAIN IN DISSEMINATED LUNG CARCINOMA PATIENTS Russian patent published in 2007 - IPC A61M1/36 A61K31/4152 A61K31/135 A61K31/522 A61K31/245 A61K31/573 A61P11/00 

FIELD: medicine.

SUBSTANCE: method involves taking 200 ml of blood from peripheral vein into flask containing hemopreservative of Glugicirum. The blood is centrifuged at 1000 rpm during 1h. Cellular mass is produced and 100-150 ml of supernatant plasma taken into Janet syringe. Plasma is introduced into the second flask containing hemopreservative of Glugicirum through sterile needle. 4 ml of 50% Analginum solution, 1 ml of 1% Dimedrolum solution, 5 ml of 2.4% Aminophylline solution are introduced into the first flask containing erythrothromboleukocytic mass. 15 ml of 0.5% Novocain, 2 ml (8 mg) of Dexamethazone is introduced into the second flask containing plasma. Both flasks are incubated at 37°C during 30 min. The second flask content and then the first flask content are intravenously drop-by-drop injected. The procedure is repeated every day twice a day with 12 h long pause.

EFFECT: enhanced effectiveness in alleviating chronic pain syndrome; reduced toxic effect manifestation.